About Heart Valve Devices
The Heart Valve Devices comprises 157 companies, including 122 funded companies having collectively raised $4.41B in venture capital money and private equity. Out of these, 81 are Series A+ funded.
Heart Valve Devices sector has seen 31 acquisitions and 6 IPOs. This represents almost 23.6% of all such companies - which is higher than the 4.2% exit rate of tech companies in general.
This sector includes companies developing therapeutic devices for the treatment of disorders related to the heart valves.
Heart Valve Devices sector is also known as Advanced Valvular Diseases or Digital Valvular Diseases.
Key Metrics
Total Companies
Top Companies
Total Funding
Funded Companies
Series A+ Companies
Series C+ Companies
IPOs
Acquisitions
Also known as
Advanced Valvular Diseases or Digital Valvular Diseases
Top Companies in Heart Valve Devices
There are more than 157 companies in Heart Valve Devices. Shockwave Medical is the top Heart Valve Devices company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Heart Valve Devices companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of cardiovascular balloon dilation catheters | Santa Clara (United States) | 2009 | Acquired | $148M | |
Developer of invasive cardiac implants for heart failure | Kirkland (United States) | 2001 | Series E | $261M | |
Developer of smart medical devices for patients with heart valve diseases | Pudong (China) | 2015 | Public | $132M | |
Developer of medical devices for the treatment of cardiac and cerebrovascular diseases | Suzhou (China) | 2012 | Public | $110M | |
Provider of pericardial transcatheter aortic valve replacement and delivery system | Irvine (United States) | 2006 | Acquired | $364M |
Companies founded year-on-year in Heart Valve Devices
8 Heart Valve Devices startups were founded in 2020 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | - |
2024 | 1 |
2023 | 1 |
2022 | - |
2021 | 3 |
2020 | 8 |
2019 | 5 |
2018 | 8 |
2017 | 6 |
Companies founded across countries in Heart Valve Devices
United States has 75 Heart Valve Devices startups, the most by any country, followed by Israel which has 23 startups and China which has 10.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 75 |
Israel | 23 |
China | 10 |
France | 7 |
Germany | 7 |
Canada | 4 |
Italy | 4 |
Ireland | 4 |
Switzerland | 4 |
United Kingdom | 3 |
Stage-wise distribution of Heart Valve Devices
Out of the total 157 Heart Valve Devices companies, 122 have secured funding. Among them, 81 have reached Series A or higher, and 65 to Series B or beyond.
Founded - 157
Funded - 122
Series A+ - 81
Series B+ - 65
Series C+ - 55
Company Stage | No. of companies |
|---|---|
Founded | 157 |
Funded | 122 |
Series A+ | 81 |
Series B+ | 65 |
Series C+ | 55 |
Want to know more about Heart Valve Devices ? Signup and explore Tracxn for free
- 155+ Total Companies
- $4.41B+ Total Funding
- 120+ Funded Companies
- 5+ IPOs
- 30+ Acquisitions
Funding Trends in Heart Valve Devices
Total funding year-on-year in Heart Valve Devices
Heart Valve Devices saw a total funding of more than $2.48B in the last 10 years. The most amount of funding was in 2020 at more than $491M. There has been a total funding of $115M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $115M |
2025 | $297M |
2024 | $230M |
2023 | $142M |
2022 | $237M |
2021 | $330M |
2020 | $491M |
2019 | $257M |
2018 | $289M |
2017 | $93.5M |
Total funding across countries in Heart Valve Devices
In the last 10 years, Heart Valve Devices startups in United States have recieved the highest funding among all countries - $1.43B. China follows with $441M and Germany with $324M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $1.43B |
China | $441M |
Germany | $324M |
Israel | $93.8M |
Italy | $88.1M |
France | $83.1M |
Ireland | $69.8M |
Norway | $56.6M |
Canada | $33.4M |
Sweden | $2.83M |
Total funding amount raised by stage in Heart Valve Devices
Over the last 10 years, Heart Valve Devices have seen $30.6M into Seed Stage funding rounds, $605M into Early Stage funding rounds and $1.58B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Late Stage | $1.58B |
Early Stage | $605M |
Post IPO | $125M |
Debt | $73.5M |
Grant | $50.2M |
Seed Stage | $30.6M |
Recent Funding Rounds in Heart Valve Devices
In the year 2026, till September 2026, Heart Valve Devices companies have raised $85M in equity funding across 4 rounds.
In the same period last year (i.e. till August 2025), Heart Valve Devices companies had raised $259M across 7 rounds.
So, 2026 has seen a 67.19% drop in funding in Heart Valve Devices companies as compared to 2025.
Here are some recent, important funding rounds in Heart Valve Devices:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series D | 7043 | Sep 01, 2026 | ||
Series C | 9367 | Aug 11, 2026 | and 1 more | |
Series B | 8913 | Jun 23, 2026 | ||
Series C | 6959 | Mar 03, 2026 | ||
Series C | 4716 | Aug 22, 2025 | - |
_1580125123202.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Top Investors in Heart Valve Devices
HHS is the top investor in Heart Valve Devices companies based on number of companies invested.
Here are some top investors in Heart Valve Devices:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Toronto (Canada) | ||
Oslo (Norway) | ||
Munich (Germany) |
_1549276469352.png?devicePixelRatio=2&height=20&width=20){kind=logo}
M&A activity in Heart Valve Devices
In the year 2026, till August 2026, 1 acquisition happened in Heart Valve Devices.
Here are some recent, important acquisitions in Heart Valve Devices:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Aug 05, 2026 | ||
Business Acquisition | Aug 20, 2024 | ||
Business Acquisition | Jul 25, 2024 | ||
Business Acquisition | Jul 15, 2024 | ||
Business Acquisition | Apr 05, 2024 |
Acquisition trends in Heart Valve Devices
Here are the acquisition trends in Heart Valve Devices:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 1 |
2025 | - |
2024 | 4 |
2023 | 1 |
2022 | 2 |
2021 | 1 |
2020 | - |
2019 | 1 |
2018 | 1 |
2017 | 3 |
IPOs in Heart Valve Devices
In the year 2024, till December 2024, 1 IPO happened in Heart Valve Devices.
Here are some recent, important IPOs in Heart Valve Devices:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Dec 13, 2024 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Oct 10, 2022 | Hong Kong Exchanges (HKG) | |
Jul 27, 2022 | Brazil Stock Exchange (B3) | |
Nov 12, 2021 | Mexican Stock Exchange (BMV) | |
Jun 14, 2021 | Euronext Exchange (Euronext) |
Colleges which produce the most Heart Valve Devices companies
Companies founded by alumni from top colleges in Heart Valve Devices
Most number of Heart Valve Devices startups have been founded by alumni from University of Pennsylvania, Stanford University and Tel Aviv University.
College | No. of companies |
|---|---|
University of Pennsylvania | 4 |
Stanford University | 3 |
Tel Aviv University | 3 |
Wharton School | 2 |
Duke University | 1 |
Harvard University | 1 |
Massachusetts Institute of Technology | 1 |
Stanford Business School | 1 |
Technion - Israel Institute of Technology | 1 |
Technion Israel Institute Technology | 1 |
Total funding in companies founded by alumni from top colleges in the Heart Valve Devices
In the last 10 years, University of Pennsylvania graduates' Heart Valve Devices companies have raised the most funding among top colleges. Wharton School alumni are second, and Stanford University alumni are third.
College | Total Funding |
|---|---|
University of Pennsylvania | $489M |
Wharton School | $203M |
Stanford University | $178M |
Stanford Business School | $157M |
Duke University | $12.8M |
Massachusetts Institute of Technology | $12.8M |
Tel Aviv University | $3.55M |
Harvard University | $3.5M |
Technion - Israel Institute of Technology | - |
Technion Israel Institute Technology | - |
Top News in Heart Valve Devices
•
TRiCares gains FDA IDE to initiate tricuspid regurgitation treatment pivotal trialclinicaltrialsarena.com•Apr 07, 2026•TRiCares
•
Peijia Medical Submits EU MDR CE Mark Application for GeminiOne TEERPR Newswire•Feb 09, 2026•Peijia Medical Technologies
•
•
Bendit Announces FDA Clearance for the Bendit17™ Steerable MicrocatheterPR Newswire•Dec 10, 2025•Bendit Technologies
•
FDA Approves Anteris Technologies’ DurAVR THV Global TrialMedical Product Outsourcing•Dec 09, 2025•Anteristech
•
•
Cardiovalve Submits CE File for Approval After Successful TARGET Study CompletionEuropa Press•Nov 17, 2025•cardiovalve
•
•
•
